Maine Medicine Weekly Update - Maine Medicine Weekly Update
October 18, 2021
(Print All Articles)

FDA Advisory Committee Recommends Moderna, J&J Boosters. What You Need to Know

A Food and Drug Administration (FDA) advisory committee voted unanimously in favor of a lower-dose Moderna COVID-19 vaccine booster on Thursday.

The recommendation from the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) was for a half booster of Moderna. Eligibility criteria was identical to eligibility criteria approved for Pfizer last month.

On Friday, the advisory committee voted unanimously on Friday to recommend a booster dose for the Johnson & Johnson COVID-19 vaccine.

Unlike the authorizations for boosters for the Pfizer-BioNTech and Moderna vaccines, no restrictions were put on the J&J booster. Johnson & Johnson representatives told the panel that a second dose given to persons 18 and older either two months or six months after the first shot increased antibody levels.

A Food and Drug Administration (FDA) advisory committee voted unanimously in favor of a lower-dose Moderna COVID-19 vaccine booster on Thursday.

The recommendation from the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) was for a half booster of Moderna. Eligibility criteria was identical to eligibility criteria approved for Pfizer last month.

  •  Individuals 65 years of age or older
  • Individuals 18 to 64 years of age at high risk of severe COVID-19
  • Individuals 18 to 64 years of age who are put at a higher risk of severe COVID-19 due to their occupation

On Friday, the advisory committee voted unanimously on Friday to recommend a booster dose for the Johnson & Johnson COVID-19 vaccine.

Unlike the authorizations for boosters for the Pfizer-BioNTech and Moderna vaccines, no restrictions were put on the J&J booster. Johnson & Johnson representatives told the panel that a second dose given to persons 18 and older either two months or six months after the first shot increased antibody levels.

Despite the committee recommending approval, an FDA summary released earlier in the week highlighted a lack of high-quality data supporting giving a booster six months following the first dose.

The VRBPAC is scheduled to meet again October 26 to discuss arequest to amend Pfizer-BioNTech’s Emergency Use Authorization (EUA) for administration of their COVID-19 mRNA vaccine to children 5 through 11 years of age. Pfizer aims to give 5- to 11-year-olds one-third of the dose given to everyone 12 and older.

Next Steps

  • The recommendation will now be taken up by the FDA leaders.
  • The F.D.A.’s acting commissioner can then issue a final determination on whether to authorize the boosters and for whom
  • An advisory panel to the US CDC reviews the F.D.A.’s decision. The panel is scheduled to meet this week.
  • The C.D.C. Director can then issue formal guidance on whether boosters should be used and who should be eligible.
  • State health departments are not obligated, but generally follow the recommendations of the US C.D.C.

Additional meeting discussions and information

Despite the unanimous vote, many committee members still had concerns over the data they saw from Moderna and the Israel Health Ministry.

Following the Moderna booster vote on Thursday, the FDA advisory committee discussed whether everyone over 18 should receive a third COVID-19 vaccine dose but several committee members pushed back on suggestions that booster shots are needed for all people, concerned the emphasis on boosters may distract from reaching unvaccinated individuals.

“The effect of a booster is much less than vaccinating unvaccinated individuals — that means both here and abroad. If we want to get out of this thing, we’ve got to vaccinate the unvaccinated.” – Advisory Committee member, Eric Rubin, editor of the New England Journal of Medicine.

The FDA is holding off on approving the Moderna Covid-19 vaccine for teens to review more data about whether it could lead in rare cases to the heart condition myocarditis. Officials want to first determine whether there is an elevated risk, and it could take several weeks.

Click here for the latest COVID-19 Information from the FDA.

Materials for the October 26th meeting concerning Pfizer’s request to amend its EUA for persons 5 to 11 years of age will be available at the Vaccines and Related Biological Products Advisory Committee meetings main page.

The meeting will be broadcast via YouTube: https://www.youtube.com/watch?v=laaL0_xKmmA&feature=youtu.be

Maine CDC Memos: Planning Efforts for Moderna Booster and Pfizer Vaccine for 5-11-year-olds

Planning is underway in anticipation of the Advisory Committee on Immunization Practices’ (ACIP) decision regarding Moderna booster vaccines. As we await ACIP’s decision next week, we are continuing to work on our planning and preparedness efforts ahead of the final decision.

 

Maine CDC is also preparing for the potential approval of an EUA for the Pfizer COVID-19 vaccine for youth ages 5-11 years old by outlining the key differences between the adult/adolescent formulation and the pediatric formulation.

Planning is underway in anticipation of the Advisory Committee on Immunization Practices’ (ACIP) decision regarding Moderna booster vaccines. As we await ACIP’s decision next week, we are continuing to work on our planning and preparedness efforts ahead of the final decision.

The proposed dosage size for Moderna’s booster dose is 0.25mL, which is half of the dosage size of the primary doses given. Please note that you will use a 1mL syringe to extract the 0.25mL booster dose.

Maine CDC is also preparing for the potential approval of an EUA for the Pfizer COVID-19 vaccine for youth ages 5-11 years old by outlining the key differences between the adult/adolescent formulation and the pediatric formulation.

Click here for Maine CDC’s message on Moderna boosters which includes the following guidance:

  • For Moderna vaccine currently in your inventory
  • For future vaccine orders after ACIP meets

Click here for the Maine CDC memo: Anticipated Emergency Use Authorization of Pfizer COVID-19 Vaccine for 5-11-year-olds.

Maine CDC will be communicating additional guidance as they receive it. over the next week. For any questions, please call the Maine Immunization Program at 207-287-3746

 

Draft Study Shows Moderna & Pfizer May Be Better Boost for J&J Recipients

A new National Institutes of Health (NIH) study suggested Moderna's or Pfizer's vaccine also work as a booster for J&J recipients and may benefit more from getting a Pfizer or Moderna vaccine as their booster instead of another J&J shot. The study is preliminary and hasn't been peer reviewed.

People who received an mRNA-based booster vaccination had a four-fold increase in their neutralization response more frequently than those who were boosted with J&J's adenovirus vaccine.

A new National Institutes of Health (NIH) study suggested Moderna's or Pfizer's vaccine also work as a booster for J&J recipients and may benefit more from getting a Pfizer or Moderna vaccine as their booster instead of another J&J shot. The study is preliminary and hasn't been peer reviewed.

People who received an mRNA-based booster vaccination had a four-fold increase in their neutralization response more frequently than those who were boosted with J&J's adenovirus vaccine.

During the Friday meeting of the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC), a top FDA official told the committee that the agency might consider allowing Johnson & Johnson recipients to receive a booster shot of the Moderna or Pfizer-BioNTech vaccines but gave no timetable for that decision.

Click here for NPR story on NIH study: NIH study of COVID-19 vaccine boosters suggests Moderna or Pfizer works best

Click here for a draft of the NIH study: Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report

FDA Schedules Advisory Committee Meeting to Discuss COVID-19 Oral Treatment

The U.S. Food and Drug Administration announced an upcoming meeting of its Antimicrobial Drugs Advisory Committee (AMDAC) to discuss Merck and Ridgeback’s request for an emergency use authorization (EUA) for molnupiravir, an investigational antiviral drug to treat COVID-19.

On Nov. 30, the advisory committee will meet to discuss the available data supporting the use of molnupiravir to treat mild-to-moderate coronavirus disease 2019 (COVID-19) in adults who have tested positive for COVID-19, and who are at high risk for progression to severe COVID-19, including hospitalization or death.

The U.S. Food and Drug Administration announced an upcoming meeting of its Antimicrobial Drugs Advisory Committee (AMDAC) to discuss Merck and Ridgeback’s request for an emergency use authorization (EUA) for molnupiravir, an investigational antiviral drug to treat COVID-19.

On Nov. 30, the advisory committee will meet to discuss the available data supporting the use of molnupiravir to treat mild-to-moderate coronavirus disease 2019 (COVID-19) in adults who have tested positive for COVID-19, and who are at high risk for progression to severe COVID-19, including hospitalization or death.

During the meeting, the committee will hear presentations from the company regarding the data for the antiviral drug. The FDA will also present its perspective regarding the sponsor’s data. There will be an open public hearing during which the public will be given an opportunity to provide comments.

Click here for the FDA media release announcing the meeting

The FDA intends to live stream the AMDAC meeting on the agency’s YouTube page

Preliminary results from a British study released in June also showed promise.

Federal COVID Vaccine Mandate Rules Have Been Drafted

The federal COVID vaccine mandate for employers with 100 or more workers testing has moved one step closer to enforcement. OSHA (Occupational Safety and Health Administration) sent a finalized initial draft of the emergency order to the Office of Management and Budget (OMB) for review. A department within OMB will conduct a standard review of the regulation.

Officials did not provide a time frame, but they have 90 days to review the rule or send it back to OSHA for revision. There is no public text of the draft. It won’t be published until OMB completes its review.

The federal COVID vaccine mandate for employers with 100 or more workers testing has moved one step closer to enforcement. OSHA (Occupational Safety and Health Administration) sent a finalized initial draft of the emergency order to the Office of Management and Budget (OMB) for review. A department within OMB will conduct a standard review of the regulation.

Officials did not provide a time frame, but they have 90 days to review the rule or send it back to OSHA for revision. There is no public text of the draft. It won’t be published until OMB completes its review.

According to Politico, the federal mandate order directs the Occupational Safety and Health Administration and Labor Department to mandate vaccination via an emergency temporary standard. These standards take effect immediately and remain in place until there’s a permanent rule that replaces it, usually within about six months of the emergency standard being set.

Click here for Associated Press story: Biden vaccine order moves closer to enforcement

President Biden announced in early September new federal vaccine requirements for certain private-sector employees, health care workers, and federal contractors.

Click here for current information from OSHA: Protecting Workers: Guidance on Mitigating and Preventing the Spread of COVID-19 in the Workplace (Updated, August 13, 2021)

One-third of Americans in the private sector work at businesses with fewer than 100 employees.

89 percent of companies have less than 20 employees.

But 64 percent of all employees work at large companies that employ 100 or more. (US Census Bureau)

 

Central Maine Healthcare Services, Staffing, Vaccine Mandate, CEO Appointment

Central Maine Medical Center announced early in the week that is was suspending pediatric and trauma admissions due to “acute nursing staffing shortages in key areas.”

State health officials signaled Wednesday that they do not plan to ease the state requirement that all health care workers at designated facilities must get vaccinated against COVID-19 by the end of the month, but said they will continue to help Central Maine Medical Center work through its staffing issues in any way they can.

Maine Republican leaders issued a media release this week after meeting with members of the leadership team at Central Maine Healthcare and members of the Androscoggin Delegation calling for the Legislature to reconvene and amend the Governor’s mandate to allow for a testing exemption.

Governor Janet Mills issued the following statement in response to Republicans in the State Legislature pushing to weaken the state’s requirement that health care workers be vaccinated against COVID-19.

People should not delay seeking emergency care at Central Maine Medical Center, the chief medical officer for the hospital’s parent company said Thursday, even as the hospital works through what its CEO called “acute staffing shortages.”

Central Maine Medical Center announced early in the week that is was suspending pediatric and trauma admissions due to “acute nursing staffing shortages in key areas.”

State health officials signaled Wednesday that they do not plan to ease the state requirement that all health care workers at designated facilities must get vaccinated against COVID-19 by the end of the month, but said they will continue to help Central Maine Medical Center work through its staffing issues in any way they can.

Maine Republican leaders issued a media release this week after meeting with members of the leadership team at Central Maine Healthcare and members of the Androscoggin Delegation calling for the Legislature to reconvene and amend the Governor’s mandate to allow for a testing exemption.

Governor Janet Mills issued the following statement in response to Republicans in the State Legislature pushing to weaken the state’s requirement that health care workers be vaccinated against COVID-19.

People should not delay seeking emergency care at Central Maine Medical Center, the chief medical officer for the hospital’s parent company said Thursday, even as the hospital works through what its CEO called “acute staffing shortages.”

---

Central Maine Healthcare appoints Steve Littleson president and CEO—Sun Journal

Littleson had been serving as the interim president and CEO since July. He took over from Jeff Brickman, the embattled former executive, who said in April that he would retire this year. Brickman continues to serve as an adviser to the board. Click here for full story and here for the CMHC media release on the announcement.

Story links:

Central Maine Medical Center temporarily stops pediatric and trauma admissions—Sun Journal

State health officials say they are working with CMMC on staffing shortages, but changes to vaccine requirement appear unlikely—Sun Journal

Republican Maine Legislative Leaders Call for Testing Exemption to Vaccine Mandate—Maine Senate GOP Website

Governor Mills Responds to Republican Leaders’ Demand to Weaken COVID-19 Public Health Measures—Governor’s website

‘Do not delay emergency care,’ Central Maine Medical Center officials say—Sun Journal

New Draft Recommendation Statement on Aspirin Use to Prevent Heart Disease and Stroke

Draft guidelines from the United States Preventative Service Task Force advises physicians to stop prescribing regular low doses of aspirin to patients at risk of a first heart attack or stroke. The new information amends the task force’s 2016 recommendation of initiating low-dose aspirin use for the primary prevention of cardiovascular disease (CVD).


Draft guidelines from the United States Preventative Service Task Force advises physicians to stop prescribing regular low doses of aspirin to patients at risk of a first heart attack or stroke. The new information amends the task force’s 2016 recommendation of initiating low-dose aspirin use for the primary prevention of cardiovascular disease (CVD).

---

Click here to read to read the media release and additional background: Task Force Issues Draft Recommendation Statement on Aspirin Use to Prevent Cardiovascular Disease (PDF)

The Task Force is seeking comments on its draft recommendation statement, draft evidence review, and draft modeling report on aspirin use to prevent cardiovascular disease. People 40 to 59 should decide with their clinician whether to start taking aspirin; people 60 and older should not start taking aspirin. The draft recommendation statement, draft evidence review, and draft modeling report are available for review and public comment from October 12, 2021 to November 8, 2021 here.

Top JAMA, JAMA Network, and New England Journal of Medicine Articles

JAMA Network Open: COVID-19 Vaccine Acceptance, Access Among Black, Latinx Communities

JAMA Network Open: Birth Volume, Geographic Distribution of U.S. Hospitals With Obstetric Services

JAMA Network Open: Electronic Health Record Messaging During Pandemic

JAMA Cardiology: Preterm Delivery and Long-term Risk of Hypertension in Women

NEJM: Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

JAMA Network Open: COVID-19 Vaccine Acceptance, Access Among Black, Latinx Communities

JAMA Network Open: Birth Volume, Geographic Distribution of U.S. Hospitals With Obstetric Services

JAMA Network Open: Electronic Health Record Messaging During Pandemic

JAMA Cardiology: Preterm Delivery and Long-term Risk of Hypertension in Women

NEJM: Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

Using Electronic Health Records to Predict Physician Departure

A new Yale study published Oct. 12 in JAMA Network Open examined whether electronic health records (EHRs), which aim to improve efficiency in healthcare but also have been associated with physician burnout, can be used to identify physicians at risk of leaving.

Researchers looked for measures associated with physician turnover. They found two:

The amount of time spent managing the EHR inbox and the portion of a physician’s orders that were placed by other team members.

Evidence of fewer contributions from team members was associated with higher rates of physician turnover

A new Yale study published Oct. 12 in JAMA Network Open examined whether electronic health records (EHRs), which aim to improve efficiency in healthcare but also have been associated with physician burnout, can be used to identify physicians at risk of leaving.

Researchers looked for measures associated with physician turnover. They found two:

The amount of time spent managing the EHR inbox and the portion of a physician’s orders that were placed by other team members.

Evidence of fewer contributions from team members was associated with higher rates of physician turnover

Click here for the Yale News story on the study.

Click here to access the study through the JAMA Network

Preventing Stimulant Misuse Among College-Aged Students

Date: October 19, 2021

Time: 9:00 - 11:00 AM ET

Topic: This Maine CDC webinar will examine psychostimulant misuse among college and college-aged students:  the prevalence, the reasons for use and misuse, and effective prevention and educational strategies to address this issue.

Date: October 19, 2021

Time: 9:00 - 11:00 AM ET

Topic: This Maine CDC webinar will examine psychostimulant misuse among college and college-aged students:  the prevalence, the reasons for use and misuse, and effective prevention and educational strategies to address this issue.

Participants will be asked to share their own experiences working with this population, including patterns they see, techniques and strategies they use, and learn new ways of increasing awareness in college community (students, faculty, administration) as well as in the larger community.

Learning Objectives:

1. Attendees will be familiar with the current trends that we are seeing in the college setting, and for young adults, ages 18-27, in terms of both prescription stimulant misuse and illicit stimulant use (cocaine and methamphetamine).

2. Attendees will be familiar with ways to engage college campuses to provide prevention strategies related to stimulant use disorder.

3. Attendees will be given examples of evidence-based stimulant use prevention resources and programming for college campus staff.

Learn More and Register: https://cvent.me/4481B9

Upcoming Specialty Society Meetings

Below you will find an on-going list of Upcoming Specialty Society Meetings. Any questions should be referred to the contact person listed for each specialty.

 

Below you will find an on-going list of Upcoming Specialty Society Meetings.  Any questions should be referred to the contact person listed for each specialty.

UPCOMING SPECIALTY SOCIETY MEETINGS

November 13, 2021
Maine Neurological Society Fall Meeting 

Maple Hill Farm – Hallowell, ME
Contact: Cathy Stratton 207-595-5725 or cstratton@mainemed.com

November 17, 2021
ACP Maine Chapter Town Hall Zoom Meeting

Via Zoom
Contact: Warene Eldridge 207-215-7118 or mainechapteracp@gmail.com

December 9, 2021
Maine Chapter – American College of Emergency Physicians
Holiday Meeting 

Portland Regency Hotel – Portland, ME
Contact: Cathy Stratton 207-595-5725 or cstratton@mainemed.com

February 25-27, 2022
Maine Society of Anesthesiologists Winter Meeting 

Sugarloaf Mountain Hotel – Carrabassett Valley, ME
Contact: Lisa Montagna 207-620-4015 or mesahq@gmail.com

March 18-20, 2022
Northern New England Urological Symposium
(Presented by the Maine Urological Association)
Grand Summit Resort Hotel & Conference Center – Newry, ME
Contact: Dianna Poulin 207-480-4194 or dpoulin@mainemed.com

March 23, 2022
3rd Annual Richard Engel, MD Primary Care Symposium

Dana Center, MMC – Portland, ME
Contact: Warene Eldridge 207-215-7118 or mainechapteracp@gmail.com

April 6-9, 2022
30th Annual Family Medicine Update & Annual Meeting
(Presented by the Maine Academy of Family Physicians)
DoubleTree by Hilton Portland – South Portland, Maine
Contact: Deborah Halbach 207-938-5005 or maineafp@tdstelme.net

April 28, 2022
Maine Association of Psychiatric Physicians Spring Conference

Theme: Eating Disorders

Hilton Garden Inn – Freeport, Maine
Contact: Dianna Poulin 207-480-4194 or dpoulin@mainemed.com

April 30 – May 1, 2022
Maine Chapter of the American Academy of Pediatrics

Samoset Resort – Rockport, ME
Contact:  Dee Kerry 207-480-4185 or dee.kerry@maineaap.org

May 6, 2022
Maine Society of Eye Physicians and Surgeons Spring Educational Program & Business Meeting

Harraseeket Inn – Freeport, ME from 11:30am – 5:00pm
Contact:  Shirley Goggin 207-445-2260 or sgoggin@mainemed.com

September 23-25, 2022
ACP Maine Chapter Annual Scientific & Chapter Meeting

Atlantic Oceanside Hotel & Conference Center – Bar Harbor, ME
Contact: Warene Eldridge 207-215-7118 or mainechapteracp@gmail.com

October 7, 2022
Maine Society of Eye Physicians and Surgeons Fall Business Meeting
(Held in conjunction with the 21st Annual Downeast Ophthalmology Symposium)

Harborside Hotel & Marina – Bar Harbor, ME from 10:30am – 11:45am
Contact:  Shirley Goggin 207-445-2260 or sgoggin@mainemed.com

October 7-9, 2022
21st Annual Downeast Ophthalmology Symposium

(Presented by the Maine Society of Eye Physicians and Surgeons)
Harborside Hotel & Marina – Bar Harbor, ME
Contact:  Shirley Goggin 207-445-2260 or sgoggin@mainemed.com

  


 

AAP EQIPP Course: Immunizations - Strategies for Success (for RURAL Health Providers)

The recently revised EQIPP immunization course is designed to identify immunization rates in your practice, uncover barriers to immunization delivery systems, and provide techniques to overcome those barriers using clear aims that reflect expert principles and proven quality improvement methods and tools.

 

The recently revised EQIPP immunization course is designed to identify immunization rates in your practice, uncover barriers to immunization delivery systems, and provide techniques to overcome those barriers using clear aims that reflect expert principles and proven quality improvement methods and tools. 

The online course features two tracks; the 19–23-month-old track and the adolescent track with data collection activities specific to each population. The course is eligible for PI CME, NAPNAP, MOC Part 2, and MOC Part 4 credits. 

The course is free to AAP members - and for a limited time, is being offered free to ALL rural health clinicians in Maine (Pediatricians AND Family Practice) through an AAP initiative.  Additional course information is available here

For rural health care providers that are non-AAP members and interested in taking this immunization course, contact Melissa Ponce at mponce@aap.org for additional information and to have your course fee waived through the Supporting Pediatricians to Improve HPV and Pediatric Influenza Vaccination Rates Initiative - again, the EQIPP immunization course is open to all Maine physicians serving youth, and the course fee is being waived for ruralhealth clinicians!

SUPPORT for ME Training and Technical Assistance Initiative

The Maine Medical Association- Center for Quality Improvement, in partnership with the Maine Department of Health and Human Services, launched the SUPPORT for ME Training and Technical Assistance initiative.

 


The Maine Medical Association- Center for Quality Improvement, in partnership with the Maine Department of Health and Human Services, launched the SUPPORT for ME Training and Technical Assistance initiative. 

This initiative is funded by the Centers for Medicare and Medicaid Services (CMS) and is designed to support the Department’s goals to enhance Maine’s response to the opioid epidemic through increased access to vital treatment and services for substance use disorder (SUD), including opioid use disorder (OUD). 

Navigate to this link for more details: SUPPORT for ME TA 

or email skring@mainemed.com

 

 

SUPPORT For ME Training and Technical Assistance Initiative Webinars on November 3 & December 1

Register now for webinars on Wednesday, November 3rd and Wednesday, December 1st from 12:00-1:00pm.

MMA-CQI: SUPPORT for ME Training and Technical Assistance to Increase Access to Medication Assisted Treatment (MAT) in the Primary Care Setting

Wednesday, November 3, 2021 12:00-1:00pm   REGISTER HERE
Treatment for Alcohol Use Disorder and Alcohol Use Disorder with Opioid Use Disorder - Complexities and Opportunities

This webinar will provide information on treatment for Alcohol Use Disorder as well as prescribing topics for Alcohol Use Disorder with Opioid Use Disorder and discussing the co-morbid use and/or treatment with patients.  After attending this webinar, participants will:

  • Understand prescribing and treatment for Alcohol Use Disorder;
  • Understand contraindications/complexities when prescribing for combined Alcohol and Opioid Use Disorders;
  • Describe how motivational interviewing can be used with patients when discussing unexpected information and the recovery journey
Speakers: Eric Haram, LADC; Elisabeth Fowlie Mock, MD, MPH; Stephanie Nichols, PharmD


Wednesday, December 1, 2021  12:00-1:00pm   REGISTER HERE
Substance Use Disorder Related Drug Screens and Lab Results - The Differences in Tests, Costs and Discussing Results
This webinar will provide information on the product options around testing as well as how to talk about unexpected lab results with your patient while still promoting their successes on the recovery journey.  After attending this webinar participants will:

  • Review the types of drug screen tests and methods;
  • Evaluate which tests work best in certain circumstances;
  • Evaluate which test results should be discussed with patients without discounting the recovery journey.

Speakers: Eric Haram, LADC; Elisabeth Fowlie Mock, MD, MPH

 

AMA Designation Statement
The Maine Medical Education Trust designates this live internet activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

Joint Sponsorship Statement
This activity has been planned and implemented in accordance with accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and the Maine Medical Association-Center for Quality Improvement (MMA-CQI).  The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.

This Support for ME Program is supported by the Centers for Medicare and Medicaid Services (CMS) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $2,144,225 with 100 percent funded by CMS/HHS.  The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CMS/HHS, or the U.S. Government.

Maine Independent Clinical Information Service: MICIS presentations & Academic Detailing

Schedule a 1-hour presentation at your medical practice or hospital, or request an individual Academic Detailing session.

The Maine Independent Clinical Information Service (MICIS) offers independent, evidence-based prescribing information directly to prescribers.

Schedule a 1-hour presentation at your medical practice or hospital.
Two topics are currently available.

  • Simplified Treatment of Hepatitis C in Primary Care Settings
  • Prescribing to Reduce Opioid Overdose Risk

Individual Academic Detailing sessions
One-on-one Academic Detailing sessions are available on these topics and can be scheduled for any time of day.

  • Level 2: Simplified Treatment of Hepatitis C in Primary Care Settings
  • Opioid Prescribing Discussion Including Maine Law
  • MAT (Medications for Addiction Treatment) Basics Discussion
  • MAT (Medications for Addiction Treatment) Advanced Discussion
  • Deprescribing Opioids & Benzodiazepines

Descriptions of presentations and Academic Detailing topics are available at https://micismaine.org/education-topics/.  Contact MICIS at https://micismaine.org/contact/ for more information and scheduling.  MICIS is a program of the Maine Medical Association.

Physician (BC/BE in Family Medicine) - Mt. Abram Regional Health Center, (Kingfield, Maine)

Mt. Abram Regional Health Center, (Kingfield, Maine) seeks aPhysician (BC/BE in Family Medicine) with outstanding clinical and interpersonal skills to provide primary care to patients of all ages in a family practice with integrated behavioral health services.

Mt. Abram Regional Health Center, (Kingfield, Maine) seeks aPhysician (BC/BE in Family Medicine) with outstanding clinical and interpersonal skills to provide primary care to patients of all ages in a family practice with integrated behavioral health services. An X waver would be desirable. The health center is part of HealthReach Community Health Centers, a system of eleven practices in central and western Maine. The selected candidate will receive a $10,000 sign-on bonus, competitive salary and benefits, malpractice coverage, pension plan with employer match, loan repayment opportunities. Contact: Recruiter, HRCHC, 10 Water Street, Suite 305, Waterville, ME 04901| Fax: (207) 660-9901 | Communications@HealthReach.org | www.MtAbramCHC.org All new hires will be required to provide either proof of COVID-19 vaccination or a recognized exemption.

10/29/21

Physician (BC/BE in Family Medicine) - Bingham Area Health Center

Bingham Area Health Center seeks a Physician (BC/BE in Family Medicine) with outstanding clinical and interpersonal skills to provide primary care to patients of all ages in a family practice with integrated behavioral health services.

Bingham Area Health Center seeks a Physician (BC/BE in Family Medicine) with outstanding clinical and interpersonal skills to provide primary care to patients of all ages in a family practice with integrated behavioral health services. An X waver would be desirable. The health center is part of HealthReach Community Health Centers, a system of eleven practices in central and western Maine. The selected candidate will receive a $10,000 sign-on bonus, competitive salary and benefits, malpractice coverage, pension plan with employer match, loan repayment opportunities. Contact: Recruiter, HRCHC, 10 Water Street, Suite 305, Waterville, ME 04901 | Fax: (207) 660-9901 | Communications@HealthReach.org | www.BinghamCHC.org. All new hires will be required to provide either proof of COVID-19 vaccination or a recognized exemption.

10/29/21